En español


118th Meeting of the National Advisory Council on Drug Abuse

Neuroscience Center - Conference Rooms C & D
6001 Executive Boulevard, Bethesda, MD.

September 2-3, 2014

Closed Session - September 2, 2014

This meeting is closed to the public in accordance with the provisions set forth in section 552b{c} and 552b{c}(6), Title 5, U.S. Code and section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2).

2:00 p.m. Call to Order
Nora Volkow, M.D., Director, NIDA

Review of and Policy Procedures
Mark Swieter, Ph.D., Acting Executive Secretary,
National Advisory Council on Drug Abuse, NIDA
2:45 p.m. Council Review of Grant Applications
Nora Volkow, M.D., Director, NIDA

Division of Clinical Neuroscience and Behavioral Research (DCNBR)
Joseph Frascella, Ph.D., Director

Division of Epidemiology, Services, and Prevention Research (DESPR)
Redonna Chandler, Ph.D., Acting Director

Division of Pharmacotherapies and Medical Consequences of Drug Abuse (DPMCDA)
Phil Skolnick, Ph.D., D.Sc. (hon.), Director

Division of Basic Neuroscience and Behavioral Research (DBNBR)
Joni Rutter, Ph.D., Director

  3:30 p.m. Adjourn

Open Session - September 3, 2014

8:30 a.m. Welcome and Presentation of Appreciation Certificates/Photographs
Nora Volkow, M.D. Director, NIDA
8:45 a.m. Director's Report
Nora Volkow, M.D. Director, NIDA
9:45 a.m. Council Discussion
Council Members
10:00 a.m. Break
10:15 a.m. Federal Drug Control Policy and Priorities: How the Biomedical Research Community Can Help
Michael Botticelli
Acting Director of National Drug Control Policy
White House Office of National Drug Control Policy
10:45 a.m.

Women’s Health Research: Moving Forward
Janine Austin Clayton, M.D.
NIH Associate Director for Research on Women’s Health
NIH Office of Research on Women’s Health

11:15 a.m.

Epigenomics Program Update
John Satterlee, Ph.D.
Roadmap Epigenomics Program
Program Director: Epigenetics, Model Organism Genetics, and Functional Genomics
Division of Basic Neuroscience and Behavioral Research

11:45 p.m. Public Comment
12:00 p.m. Adjourn


This page was last updated August 2014